• Explore /
  • Poster
  • / Subtype analysis from the GEICAM/2003-02 study: High-risk, node-negative breast cancer patients treated with adjuvant fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus FAC followed by weekly paclitaxel.

Subtype analysis from the GEICAM/2003-02 study: High-risk, node-negative breast cancer patients treated with adjuvant fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus FAC followed by weekly paclitaxel.

Abstract Poster

Authors

null

Federico Rojo

Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain

Federico Rojo , Ana Lluch , Amparo Ruiz , Manuel Ruiz-Borrego , Agusti Barnadas , Lourdes Calvo , Sonia Gonzalez , Mireia Margeli , Alvaro Rodriguez-Lescure , Antonio Anton , Miguel Angel Seguí , Montserrat Munoz-Mateu , Joan Dorca , Jose Manuel Lopez-Vega , Carlos Jara-Sanchez , Nuria Martin , Maribel Casas , Eva Maria Carrasco , Rosalia Caballero , Miguel Martin

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Tumor Biology

Track

Tumor Biology

Sub Track

Molecular Diagnostics and Imaging

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 11107)

DOI

10.1200/jco.2014.32.15_suppl.11107

Abstract #

11107

Poster Bd #

389

Abstract Disclosures

Similar Posters

First Author: Rebecca Arielle Shatsky

First Author: Kay T Yeung

First Author: M. Luque

First Author: Sheridan Marie Wilson